Cargando…
In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions
The aim was to evaluate the potential of mucus-permeating nanoparticles for the oral administration of insulin. These nanocarriers, based on the coating of zein nanoparticles with a polymer conjugate containing PEG, displayed a size of 260 nm with a negative surface charge and an insulin payload of...
Autores principales: | Martínez-López, Ana L., González-Navarro, Carlos J., Aranaz, Paula, Vizmanos, José L., Irache, Juan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105877/ https://www.ncbi.nlm.nih.gov/pubmed/33996411 http://dx.doi.org/10.1016/j.apsb.2021.02.020 |
Ejemplares similares
-
Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization
por: Gamazo, Carlos, et al.
Publicado: (2015) -
Phenolic Compounds Reduce the Fat Content in Caenorhabditis elegans by Affecting Lipogenesis, Lipolysis, and Different Stress Responses
por: Aranaz, Paula, et al.
Publicado: (2020) -
Optimizing simple calreticulin upregulation strategies in Caenorhabditis elegans
por: Guijarro-Hernández, Ana, et al.
Publicado: (2022) -
Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus
por: Wright, Leah, et al.
Publicado: (2022) -
Monitoring Caenorhabditis elegans molting in a conventional luminometer
por: Guijarro-Hernández, Ana, et al.
Publicado: (2023)